Greatness in Tech

Yesterday, Business Insider released its “Silicon Valley 100” list, a collection of the most powerful, collaborative forces featuring the largest and newest names in the industry. We all read this, but we often don’t talk about the kind of impact achievement and influence like this can have on motivating an entire generation of tech start ups and elementary schoolers taking coding and computer science classes for the first time.

It’s nice to be recognized for the work you do, but ending up on the Silicon Valley 100 list isn’t just about vanity. It’s a statement that what you’re doing is so special and so valuable to the interests of technology that the entire world needs to know who you are. These are people managing massive juggernauts and rapidly growing startups. This list means that you’re making it more than almost anyone you could possibly know.

For those of us who are passionate about the work we’re doing in tech, from investing to development and beyond, being recognized for our work makes us feel good, but it could also be the difference between thousands and thousands of dollars in valuation and profits, so getting on this list is a veritable golden ticket.

I know I want to make it easy for every child in America to have a computer, which is an obvious tech goal, but I also want to use tech to connect poor people to fresh food sources, a more complex goal.

Who knows, maybe you’ll see me on the Silicon Valley 100 someday.

Good News in the UK For International Development and Tech

It turns out that there is good news from the U.K. The U.K. has committed 100 million pounds to help nearly 175,000 of the poorest girls in the world get an education and have some access to technology as well. This money will mostly be spend in Africa, with some funds going to Asia and the Middle East.

This is great news. Sometimes, I think it would be great if the entire world could learn to start finding other ways to satisfy its obsession with technology, the internet, and hyper-connectivity. However, I realize that the rest of the world does not think that way and technology is becoming an increasingly singular way for the world to engage in trade, communication, research and development, and security management. If we want the poorest countries to be able to grow their economies and provide for a stable, healthy future for themselves, we have to be willing to invest in them the technology they need to compete with the entire world and at least have some semblance of the life we hope for our own children.

Chances are, if you’re reading this, you’re in the top of half of wealthiest individuals in the entire world, believe it or not. That’s the case whether you’re reading this in a mansion or a farmhouse. Those of us in countries that have benefited from technology this far have some moral obligation to ensure that other countries can join us in benefiting from technology in the future.

Dr. Mark J. Ahn, Business Executive, Entrepreneur & Author

Dr. Mark Ahn is a well known Biotechnology business executive. He is an innovative and accomplished leader in the industry and has taken up numerous leadership roles in his career spanning over 20 years. He is a PHD in philosophy and has been a part of many leading biotech companies. He is also known for his entrepreneurial genius.

EDUCATION:

Dr. Mark Ahn is a well rounded business executive with education from varied backgrounds. He acquired his Bachelor of Arts (BA) from Chaminade University of Honolulu. He later went on to acquire his MBA from the same university. With the urge to get going, Dr. Mark Ahn received his Masters degree in Arts from the Victoria University of Wellington.

He continued his education by getting his PHD from the University of South Australia as a Doctor of Philosophy. He was also a graduate fellow in Economics at Essex University, and a Henry Crown Fellow at the Aspen Institute.

With quantum of knowledge under his belt and decades of experience in business consulting in the bio-sciences department, Dr. Mark Ahn is a very reputed name in the business circles!

CAREER:

Dr. Mark J. Ahn’s work in the bio-science and biotech field is a career spanning over 20 years. In these 20 years Dr. Ahn has taken up leadership roles and responsibilities in many biotech industries, big and small. He started career working for the industry leader Amgen, acting as a general manager for 6 years. He later moved to Bristol-Myers Squibb, New Jersey, as a Senior Director for Immunology department. His services lasted for over 4 years in this company. He even acted as a Vice President of Hematology department in Genentech, San Francisco for 2 years.

Between the years 2007-2014, Dr. Mark Ahn also acted as the President and CEO, Director of Galena Biopharma, a company focused on innovative medical therapies to address various unmet needs of the public.

ENTREPRENEURSHIP:

After his services at Genentech, Dr. Mark Ahn shifted his focus towards Entrepreneurship. With the goal to start a biotech company he laid foundations to his own company and launched Hana Biosciences, where he served as the President and Chief Executive Officer until eventually selling the company to Spectrum Pharmaceuticals in 2007.

Later on in 2009, he launched his successful Biotechnology consulting company, Pukana Partner, which was aimed at providing business analytic solutions and strategies to accelerate value creation for biotechnology companies. Dr. Ahn is the Principal of the company.

AUTHOR:

Dr. Mark J. Ahn has authored over 50 journal articles and books. His two well known works include: “Building the Case for Biotechnology: Management Case Studies in Science, Laws, Regulations, Politics, and Business” and “Strategic Risk Management: How Global Corporations Manage Financial Risk for Competitive Advantage”. Both of these were co-authored by Dr. Mark Ahn.

OTHER ACTIVITIES:

Dr. Mark J. Ahn is also an adjunct Professor at Portland State University and Caregie Mellon University and a strategy consultant in the biotechnology industry. He is a profound writer and his publications are known for their focus on Entrepreneurship, Life sciences, innovation and business analytics.

He is presently acting as the Principal for his biotechnology consulting company Pukana Partners and he spends his time helping bio-science companies to improve their business.